The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota
Open accessAbstract
Several strains of lactic acid bacteria are potent probiotics and can cure a variety of diseases using different modes of actions. These bacteria produce antimicrobial peptides, bacteriocins, which inhibit or kill generally closely related bacterial strains and other pathogenic bacteria such as Listeria, Clostridium , and Salmonella . Bacteriocins are cationic peptides that kill the target cells by pore formation and the dissipation of cytosolic contents, leading to cell death. Bacteriocins are also known to modulate native microbiota and host immunity, affecting several health-promoting functions of the host. In this review, we have discussed the ability of bacteriocin-producing probiotic lactic acid bacteria in the modulation of gut microbiota correcting dysbiosis and treatment/maintenance of a few important human disorders such as chronic infections, inflammatory bowel diseases, obesity, and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zheng, J., Wittouck, S., Salvetti, E., Franz, C. M. A. P., Harris, H. M. B., Mattarelli, P., O’Toole, P. W., Pot, B., Vandamme, P., Walter, J., et al. (2020) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijsem.0.004107 · Cited by 3,313
Turnbaugh, P. J., Bäckhed, F., Fulton, L., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.02.015 · Cited by 2,915
A microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340
Dysbiosis of the gut microbiota in disease
Carding, S., Verbeke, K., Vipond, D. T., Corfe, B. M., & Owen, L. J. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.26191 · Cited by 1,710
Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria
Macpherson, A. J., & Uhr, T. (2004) · Science · doi:10.1126/science.1091334 · Cited by 1,584 · cited 1×
“DC protects feasible gut microflora and dispatches microorganisms to “mesenteric lymph nodes” and results in the production of IgA antibodies to defend the opposition of mucosal invasion (Macpherson and Uhr, 2004; Macpherson et al., 2005).”
BackgroundThe vagus nerve at the interface of the microbiota-gut-brain axis
Bonaz, B., Bazin, T., & Pellissier, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00049 · Cited by 1,397
Worldwide Variations in Colorectal Cancer
Center, M. M., Jemal, A., Smith, R. A., & Ward, E. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20038 · Cited by 1,276
The microbiome-gut-brain axis in health and disease
Dinan, T. G., & Cryan, J. F. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.09.007 · Cited by 1,111
Bifidobacteria and Their Role as Members of the Human Gut Microbiota
O'Callaghan, A., & van Sinderen, D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00925 · Cited by 1,080
Impacts of gut bacteria on human health and diseases
Zhang, Y.-J., Li, S., Gan, R.-Y., Zhou, T., Xu, D.-P., & Li, H.-B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16047493 · Cited by 1,055
Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity
Liou, A. P., Paziuk, M., Luevano, J.-M., Machineni, S., Turnbaugh, P. J., & Kaplan, L. M. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005687 · Cited by 1,007
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases
Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804 · cited 2×
“Alteration in the gut microbiota is connected to several neurological disorders (Cox and Weiner, 2018), which involve not only hypertension and stress (Nagpal et al., 2018) but also neurodegenerative diseases (Quigley, 2017) and refractory epilepsy (Braakman and Van Ingen, 2018).”
BackgroundProbiotic species in the modulation of gut microbiota: An overview
Azad, M. A. K., Sarker, M., Li, T., & Yin, J. (2018) · BioMed Research International · doi:10.1155/2018/9478630 · Cited by 803
Furrie, E., Macfarlane, S., Kennedy, A., Cummings, J. H., Walsh, S. V., O’Neil, D. A., & Macfarlane, G. T. (2005) · Gut · doi:10.1136/gut.2004.044834 · Cited by 766
Walter, J. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00753-08 · Cited by 751
Antibacterial activities of bacteriocins: application in foods and pharmaceuticals
Yang, S.-C., Lin, C.-H., Sung, C. T., & Fang, J.-Y. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00241 · Cited by 726
Michielan, A., & D’Incà, R. (2015) · Mediators of Inflammation · doi:10.1155/2015/628157 · Cited by 709
Mokoena, M. P. (2017) · Molecules · doi:10.3390/molecules22081255 · Cited by 672
Gut microbiome and aging: physiological and mechanistic insights
Nagpal, R., Mainali, R., Ahmadi, S., Wang, S., Singh, R., Kavanagh, K., Kitzman, D. W., Kushugulova, A., Marotta, F., & Yadav, H. (2018) · Nutrition and Healthy Aging · doi:10.3233/nha-170030 · Cited by 670
Molecular mechanisms of membrane targeting antibiotics
Epand, R. M., Walker, C., Epand, R. F., & Magarvey, N. A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.10.018 · Cited by 666
The Gut Microbiome and the Brain
Galland, L. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2014.7000 · Cited by 648 · cited 1×
“The outcome to these neural changes in the brain can guide to destruction, hypertension, and other coherent diseases (Saunders et al., 2002; Galland, 2014; Johnson and Foster, 2018; Angelucci et al., 2019).”
BackgroundGut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Fong, W., Li, Q., & Yu, J. (2020) · Oncogene · doi:10.1038/s41388-020-1341-1 · Cited by 613
Effects of antibiotics on gut microbiota
Lange, K., Buerger, M., Stallmach, A., & Bruns, T. (2016) · Digestive Diseases · doi:10.1159/000443360 · Cited by 607 · cited 1×
“The perturbation in the commensal gut microbial flora causes dysbiosis, which happens due to several factors like imbalanced diet, infection, or the use of antibiotics, which can cause a long-term shift in the gut commensal microflora, promoting a large number of deadly diseases (Lange et al., 2016).”
BackgroundBiomedical applications of nisin
Shin, J. M., Gwak, J. W., Kamarajan, P., Fenno, J. C., Rickard, A. H., & Kapila, Y. L. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13033 · Cited by 607
Looking for a Signal in the Noise: Revisiting Obesity and the Microbiome
Sze, M. A., & Schloss, P. D. (2016) · mBio · doi:10.1128/mbio.01018-16 · Cited by 600 · cited 1×
“The imbalance was identified by a decrease in the number of Gram-negative aerobes and anaerobe Bacteroidetes and increase in Gram-positive Firmicutes (Sze and Schloss, 2016).”
BackgroundNovel bacteriocins from lactic acid bacteria (LAB): various structures and applications
Perez, R. H., Zendo, T., & Sonomoto, K. (2014) · Microbial Cell Factories · doi:10.1186/1475-2859-13-s1-s3 · Cited by 575
Lactic acid bacteria as starter cultures: An update in their metabolism and genetics
Bintsis, T., & Department of Agricultural Technology, T. O. W. M. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.4.665 · Cited by 570
Microcins mediate competition among Enterobacteriaceae in the inflamed gut
Sassone-Corsi, M., Nuccio, S.-P., Liu, H., Hernandez, D., Vu, C. T., Takahashi, A. A., Edwards, R. A., & Raffatellu, M. (2016) · Nature · doi:10.1038/nature20557 · Cited by 549
Wang, H.-X., & Wang, Y.-P. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.190667 · Cited by 546
Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations
Soltani, S., Hammami, R., Cotter, P. D., Rebuffat, S., Said, L. B., Gaudreau, H., Bédard, F., Biron, E., Drider, D., & Fliss, I. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa039 · Cited by 544
Rea, M. C., Sit, C. S., Clayton, E., O'Connor, P. M., Whittal, R. M., Zheng, J., Vederas, J. C., Ross, R. P., & Hill, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913554107 · Cited by 530
Criteria to Qualify Microorganisms as “Probiotic” in Foods and Dietary Supplements
Binda, S., Hill, C., Johansen, E., Obis, D., Pot, B., Sanders, M. E., Tremblay, A., & Ouwehand, A. C. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01662 · Cited by 519
Colman, R. J., & Rubin, D. T. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.08.006 · Cited by 475
Antibiotics, gut microbiota, and Alzheimer’s disease
Angelucci, F., Cechova, K., Amlerova, J., & Hort, J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1494-4 · Cited by 454
Bacteriocins Produced by Lactic Acid Bacteria a Review Article
Zacharof, M. P., & Lovitt, R. W. (2012) · APCBEE Procedia · doi:10.1016/j.apcbee.2012.06.010 · Cited by 431
Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier
Liu, Q., Yu, Z., Tian, F., Zhao, J., Zhang, H., Zhai, Q., & Chen, W. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-1289-4 · Cited by 427
The dual role of bacteriocins as anti- and probiotics
Gillor, O., Etzion, A., & Riley, M. A. (2008) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-008-1726-5 · Cited by 416
Immunomodulatory Effects of Probiotics in the Intestinal Tract
(2008) · Current Issues in Molecular Biology · doi:10.21775/cimb.010.037 · Cited by 400
The microbiome-shaping roles of bacteriocins
Heilbronner, S., Krismer, B., Brötz-Oesterhelt, H., & Peschel, A. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00569-w · Cited by 395
Antimicrobial Activity of Lactic Acid Bacteria Against Listeria monocytogenes
Harris, L. J., Daeschel, M. A., Stiles, M. E., & Klaenhammer, T. R. (1989) · Journal of Food Protection · doi:10.4315/0362-028x-52.6.384 · Cited by 362
Why does the microbiome affect behaviour?
Johnson, K. V.-A., & Foster, K. R. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0014-3 · Cited by 333
The Impact of Microbiota on Brain and Behavior: Mechanisms & Therapeutic Potential
Borre, Y. E., Moloney, R. D., Clarke, G., Dinan, T. G., & Cryan, J. F. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_17 · Cited by 329
Targeting DnaN for tuberculosis therapy using novel griselimycins
Kling, A., Lukat, P., Almeida, D. V., Bauer, A., Fontaine, E., Sordello, S., Zaburannyi, N., Herrmann, J., Wenzel, S. C., König, C., et al. (2015) · Science · doi:10.1126/science.aaa4690 · Cited by 316
Gut Microbiota, Immune System, and Bone
D’Amelio, P., & Sassi, F. (2018) · Calcified Tissue International · doi:10.1007/s00223-017-0331-y · Cited by 315
Schlee, M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T. A., Stange, E. F., & Fellermann, K. (2007) · Infection and Immunity · doi:10.1128/iai.01563-06 · Cited by 315
Xue, L., He, J., Gao, N., Lu, X., Li, M., Wu, X., Liu, Z., Jin, Y., Liu, J., Xu, J., et al. (2017) · Scientific Reports · doi:10.1038/srep45176 · Cited by 305
Gut bacterial microbiota and obesity
Million, M., Lagier, J.-C., Yahav, D., & Paul, M. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12172 · Cited by 287
Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria
Macpherson, A. J., Geuking, M. B., & McCoy, K. D. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02159.x · Cited by 283
Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus
Kim, S. G., Becattini, S., Moody, T. U., Shliaha, P. V., Littmann, E. R., Seok, R., Gjonbalaj, M., Eaton, V., Fontana, E., Amoretti, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1501-z · Cited by 283
A Key Role of Dendritic Cells in Probiotic Functionality
Foligne, B., Zoumpopoulou, G., Dewulf, J., Ben Younes, A., Chareyre, F., Sirard, J.-C., Pot, B., & Grangette, C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000313 · Cited by 279
Mileti, E., Matteoli, G., Iliev, I. D., & Rescigno, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007056 · Cited by 272
Bacteriocins as Potential Anticancer Agents
Kaur, S., & Kaur, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00272 · Cited by 269
Emerging roles of lactic acid bacteria in protection against colorectal cancer
Zhong, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i24.7878 · Cited by 256
Hernández-González, J. C., Martínez-Tapia, A., Lazcano-Hernández, G., García-Pérez, B. E., & Castrejón-Jiménez, N. S. (2021) · Animals · doi:10.3390/ani11040979 · Cited by 256
Microbiome, inflammation, epigenetic alterations, and mental diseases
Alam, R., Abdolmaleky, H. M., & Zhou, J. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32567 · Cited by 240 · cited 1×
“Furthermore, the gut microbiota produce other proteins that are the deleterious substitute of CNS, being robust irritant cytokines and inborn response activator B cells in the host (Alam et al., 2017).”
BackgroundGut Microbiota and Diarrhea: An Updated Review
Li, Y., Xia, S., Jiang, X., Feng, C., Gong, S., Ma, J., Fang, Z., Yin, J., & Yin, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.625210 · Cited by 219 · cited 1×
“Rotavirus is a double-stranded RNA-lacking envelope that causes the destruction of epithelial cell lining in infants, causing diarrhea (Li et al., 2021).”
BackgroundAntiviral Potential of Lactic Acid Bacteria and Their Bacteriocins
Al Kassaa, I., Hober, D., Hamze, M., Chihib, N. E., & Drider, D. (2014) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-014-9162-6 · Cited by 217
Dietary Neurotransmitters: A Narrative Review on Current Knowledge
Briguglio, M., Dell’Osso, B., Panzica, G., Malgaroli, A., Banfi, G., Zanaboni Dina, C., Galentino, R., & Porta, M. (2018) · Nutrients · doi:10.3390/nu10050591 · Cited by 212
Bjarnason, I., Sission, G., & Hayee, B. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00595-4 · Cited by 208
Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and Utility
Scaldaferri, F., Gerardi, V., Lopetuso, L. R., Del Zompo, F., Mangiola, F., Boškoski, I., Bruno, G., Petito, V., Laterza, L., Cammarota, G., et al. (2013) · BioMed Research International · doi:10.1155/2013/435268 · Cited by 207
Microbiota Signaling Pathways that Influence Neurologic Disease
Cox, L. M., & Weiner, H. L. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0598-8 · Cited by 207
Current Applications of Bacteriocin
Negash, A. W., & Tsehai, B. A. (2020) · International Journal of Microbiology · doi:10.1155/2020/4374891 · Cited by 206
Saunders, P. R., Santos, J., Hanssen, N. P. M., Yates, D., Groot, J. A., & Perdue, M. H. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1013204612762 · Cited by 198
Probiotics: How Effective Are They in the Fight against Obesity?
Mazloom, K., Siddiqi, I., & Covasa, M. (2019) · Nutrients · doi:10.3390/nu11020258 · Cited by 192
Characterisation of an antiviral pediocin-like bacteriocin produced by Enterococcus faecium
Todorov, S. D., Wachsman, M., Tomé, E., Dousset, X., Destro, M. T., Dicks, L. M. T., de Melo Franco, B. D. G., Vaz-Velho, M., & Drider, D. (2010) · Food Microbiology · doi:10.1016/j.fm.2010.05.001 · Cited by 189
Antimicrobial activity of lacticin 3147 against clinical Clostridium difficile strains
Rea, M. C., Clayton, E., O'Connor, P. M., Shanahan, F., Kiely, B., Ross, R. P., & Hill, C. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47085-0 · Cited by 186
Modulation of the gut microbiota by prebiotic fibres and bacteriocins
Umu, Ö. C. O., Rudi, K., & Diep, D. B. (2017) · Microbial Ecology in Health and Disease · doi:10.1080/16512235.2017.1348886 · Cited by 185
Effect of Lactobacillus salivarius Bacteriocin Abp118 on the Mouse and Pig Intestinal Microbiota
Riboulet-Bisson, E., Sturme, M. H. J., Jeffery, I. B., O'Donnell, M. M., Neville, B. A., Forde, B. M., Claesson, M. J., Harris, H., Gardiner, G. E., Casey, P. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031113 · Cited by 177
Current Knowledge of the Mode of Action and Immunity Mechanisms of LAB-Bacteriocins
Pérez-Ramos, A., Madi-Moussa, D., Coucheney, F., & Drider, D. (2021) · Microorganisms · doi:10.3390/microorganisms9102107 · Cited by 175
Zeuthen, L. H., Fink, L. N., & Frøkiær, H. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02800.x · Cited by 173
Hoarau, C., Lagaraine, C., Martin, L., Velge-Roussel, F., & Lebranchu, Y. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.10.043 · Cited by 171
Martin-Visscher, L. A., van Belkum, M. J., Garneau-Tsodikova, S., Whittal, R. M., Zheng, J., McMullen, L. M., & Vederas, J. C. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00817-08 · Cited by 164
Structure and genetics of circular bacteriocins
van Belkum, M. J., Martin‐Visscher, L. A., & Vederas, J. C. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.04.004 · Cited by 162
Millette, M., Cornut, G., Dupont, C., Shareck, F., Archambault, D., & Lacroix, M. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02150-07 · Cited by 158
Antibacterial Peptides “Bacteriocins”: An Overview of Their Diverse Characteristics and Applications
NISHIE, M., NAGAO, J.-I., & SONOMOTO, K. (2012) · Biocontrol Science · doi:10.4265/bio.17.1 · Cited by 158
Secretome of Intestinal Bacilli: A Natural Guard against Pathologies
Ilinskaya, O. N., Владимировна, У. В., Рашидовна, Я. Д., & Гатауллин, И. Г. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01666 · Cited by 157
Heeney, D. D., Zhai, Z., Bendiks, Z., Barouei, J., Martinic, A., Slupsky, C. M., & Marco, M. L. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1534513 · Cited by 149
Borrero, J., Brede, D. A., Skaugen, M., Diep, D. B., Herranz, C., Nes, I. F., Cintas, L. M., & Hernández, P. E. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.01173-10 · Cited by 147
Probiotics for the Treatment of Overweight and Obesity in Humans—A Review of Clinical Trials
Wiciński, M., Gębalski, J., Gołębiewski, J., & Malinowski, B. (2020) · Microorganisms · doi:10.3390/microorganisms8081148 · Cited by 147
Bacteriocins: Potential for Human Health
Huang, F., Teng, K., Liu, Y., Cao, Y., Wang, T., Ma, C., Zhang, J., & Zhong, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5518825 · Cited by 146
The Potential of Class II Bacteriocins to Modify Gut Microbiota to Improve Host Health
Umu, Ö. C. O., Bäuerl, C., Oostindjer, M., Pope, P. B., Hernández, P. E., Pérez‐Martínez, G., & Diep, D. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164036 · Cited by 144
Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model
Goldstein, B. P. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.277 · Cited by 142
Bacteriocins: Perspective for the development of novel anticancer drugs
Baindara, P., Korpole, S., & Grover, V. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9420-8 · Cited by 139
Dabour, N., Zihler, A., Kheadr, E., Lacroix, C., & Fliss, I. (2009) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2009.05.005 · Cited by 132
Norouzi, Z., Salimi, A., Halabian, R., & Fahimi, H. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.07.006 · Cited by 126
Anorexia Nervosa and the Immune System—A Narrative Review
Gibson, D., & Mehler, P. S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111915 · Cited by 125
Probiotics: A potential immunomodulator in COVID-19 infection management
Singh, K., & Rao, A. (2021) · Nutrition Research · doi:10.1016/j.nutres.2020.12.014 · Cited by 120
Nisin F in the treatment of respiratory tract infections caused byStaphylococcus aureus
de Kwaadsteniet, M., ten Doeschate, K., & Dicks, L. M. T. (2008) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2008.02488.x · Cited by 119
Baba, N., Samson, S., Bourdet‐Sicard, R., Rubio, M., & Sarfati, M. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108017 · Cited by 117
Chi, H., & Holo, H. (2017) · Current Microbiology · doi:10.1007/s00284-017-1375-y · Cited by 116
Shadnoush, M., Hosseini, R. S., Khalilnezhad, A., Navai, L., Goudarzi, H., & Vaezjalali, M. (2015) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2015.65.4.215 · Cited by 115
Lactobacillus acidophilus modulates the virulence of Clostridium difficile
Yun, B., Oh, S., & Griffiths, M. W. (2014) · Journal of Dairy Science · doi:10.3168/jds.2014-7921 · Cited by 115
Probiotics at War Against Viruses: What Is Missing From the Picture?
Tiwari, S. K., Dicks, L. M. T., Popov, I. V., Karaseva, A. B., Ermakov, A. M., Suvorov, A. N., Tagg, J. R., Weeks, R. M., & Chikindas, M. L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01877 · Cited by 112
Self-citationLehtoranta, L., Latvala, S., & Lehtinen, M. J. (2020) · Nutrients · doi:10.3390/nu12103163 · Cited by 103
Behrouz, V., Jazayeri, S., Aryaeian, N., Zahedi, M. J., & Hosseini, F. Z. (2017) · Middle East Journal of Digestive Diseases · doi:10.15171/mejdd.2017.66 · Cited by 97
Belfiore, C., Castellano, P., & Vignolo, G. M. (2006) · Food Microbiology · doi:10.1016/j.fm.2006.05.006 · Cited by 88
Antiviral activity of enterocin CRL35 against herpesviruses
Wachsman, M. B., Farías, M. E., Takeda, E., Sesma, F. J. M., Holgado, A. P. D. R., de Torres, R. A., & Coto, C. E. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00078-3 · Cited by 83
de Kwaadsteniet, M., Fraser, T., van Reenen, C. A., & Dicks, L. M. T. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.00436-06 · Cited by 80
Effect of nisin and doxorubicin on DMBA-induced skin carcinogenesis—a possible adjunct therapy
Preet, S., Bharati, S., Panjeta, A., Tewari, R., & Rishi, P. (2015) · Tumor Biology · doi:10.1007/s13277-015-3571-3 · Cited by 78
Liu, G., Ren, W., Fang, J. Q., Hu, C. A., Guan, G., Al-Dhabi, N. A., Yin, J., Duraipandiyan, V., Chen, S., Peng, Y., et al. (2017) · Amino Acids · doi:10.1007/s00726-017-2410-9 · Cited by 76
Chang, J. Y., & Chang, H. C. (2011) · Journal of Food Science · doi:10.1111/j.1750-3841.2010.01965.x · Cited by 74
Birri, D. J., Brede, D. A., Forberg, T., Holo, H., & Nes, I. F. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01597-09 · Cited by 74
Health claims substantiation for probiotic and prebiotic products
Sanders, M. E., Heimbach, J. T., Pot, B., Tancredi, D. J., Lenoir-Wijnkoop, I., Lähteenmäki-Uutela, A., Gueimonde, M., & Bañares, S. (2011) · Gut Microbes · doi:10.4161/gmic.2.3.16174 · Cited by 72
Can epilepsy be treated by antibiotics?
Braakman, H. M. H., & van Ingen, J. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8943-3 · Cited by 70
Role of Probiotics and Their Metabolites in Inflammatory Bowel Diseases (IBDs)
Toumi, R., Samer, A., Soufli, I., Rafa, H., & Touil–Boukoffa, C. (2021) · Gastroenterology Insights · doi:10.3390/gastroent12010006 · Cited by 61
Cavicchioli, V. Q., de Carvalho, O. V., de Paiva, J. C., Todorov, S. D., Silva‐Júnior, A., & Nero, L. A. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.04.020 · Cited by 59
Evaluation of immunomodulatory effects of nisin-containing diets on mice
PABLO, M. A. D., Gaforio, J. J., Gallego, A. M., et al. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1999.tb01262.x · Cited by 57
Sidhu, M., & van der Poorten, D. (2017) · PubMed · Cited by 57
Goyal, C., Malik, R. K., & Pradhan, D. (2018) · Journal of Food Science and Technology · doi:10.1007/s13197-018-3298-4 · Cited by 55
Prebiotic and Synbiotic Treatment before Colorectal Surgery--Randomised Double Blind Trial.
Krebs, B. (2016) · PubMed · Cited by 52
Jia, Z., Chen, A., Bao, F., He, M., Gao, S., Xu, J., Zhang, X., Niu, P., & Wang, C. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.04.005 · Cited by 48
Enterocin CRL35 Inhibits Listeria monocytogenes in a Murine Model
Salvucci, E., Saavedra, L., Hebert, E. M., Haro, C., & Sesma, F. J. M. (2011) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2011.0972 · Cited by 47
Bacteriotherapy in gastrointestinal cancer
Soleimanpour, S., Hasanian, S. M., Avan, A., Yaghoubi, A., & Khazaei, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117754 · Cited by 47
Wu, S., Yuan, L., Zhang, Y., Liu, F., Li, G., Wen, K., Kocher, J., Yang, X., & Sun, J. (2013) · Gut Pathogens · doi:10.1186/1757-4749-5-22 · Cited by 46
Action mode of bacteriocin BM1829 against Escherichia coli and Staphylococcus aureus
Yan, H., Lu, Y., Li, X., Yi, Y., Wang, X., Shan, Y., Liu, B., Zhou, Y., & Lü, X. (2020) · Food Bioscience · doi:10.1016/j.fbio.2020.100794 · Cited by 46
Papaconstantinou, H. T., & Thomas, J. K. (2007) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-2007-970196 · Cited by 43
Kwok, L. Y., Guo, Z., Zhang, J., Wang, L., Qiao, J., Hou, Q., Zheng, Y., & Zhang, H. (2015) · Beneficial Microbes · doi:10.3920/bm2014.0063 · Cited by 41
Connor, P. M. O., Shea, E. F. O., Cotter, P. D., Hill, C., & Ross, R. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-30271-6 · Cited by 37
Dey, D., Ema, T. I., Biswas, P., Aktar, S., ISLAM, S., Rinik, U. R., Firoz, M., Ahmed, S. Z., Azad, S. A., Rahman, A., et al. (2021) · Frontiers of Agricultural Science and Engineering · doi:10.15302/j-fase-2021397 · Cited by 36
Antiviral Potential of Selected Starter Cultures, Bacteriocins and d,l-Lactic Acid
Lange-Starke, A., Petereit, A., Truyen, U., Braun, P. G., Fehlhaber, K., & Albert, T. (2013) · Food and Environmental Virology · doi:10.1007/s12560-013-9135-z · Cited by 34
Bai, L., Kumar, S., Verma, S., & Seshadri, S. (2020) · 3 Biotech · doi:10.1007/s13205-020-02317-y · Cited by 33
Abdi, M., Lohrasbi, V., Asadi, A., Esghaei, M., Jazi, F. M., Rohani, M., & Talebi, M. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104998 · Cited by 33
Sheoran, P., & Tiwari, S. K. (2020) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-020-09708-w · Cited by 28
Self-citationSalman, J. A. S., Mahmood, N. N., Abdulsattar, B. O., & Abid, H. A. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.5483 · Cited by 16
Cited by
Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review
Zhao, M., Chu, J., Feng, S., Guo, C., Xue, B., He, K., & Li, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114985 · Cited by 458
da Silva, T. F., Glória, R. D. A., de Sousa, T. J., Americo, M. F., Freitas, A. D. S., Viana, M. V. C., de Jesus, L. C. L., da Silva Prado, L. C., Daniel, N., Ménard, O., et al. (2023) · BMC Microbiology · doi:10.1186/s12866-023-03112-4 · Cited by 11
Metadata
- Authors
- Anjana, & Tiwari, S. K.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2022-05-16
- Volume
- 12
- Pages
- 851140-851140
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W4280609688
- Cited by
- 264
- References
- 124
- FWCI
- 25.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.